Skip to content

The Effect of a Ketone Drink on Blood Glucose Levels in People With Type 2 Diabetes

Investigating the Blood Glucose Lowering Effect of Exogenous Ketone Ingestion in People With Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06324669
Enrollment
15
Registered
2024-03-22
Start date
2024-03-16
Completion date
2025-01-26
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

Ketones are naturally produced by our body and can affect our blood sugar levels. Ketones could be important in the treatment of type 2 diabetes (T2D). The purpose of this research is to determine if a ketone drink can lower blood sugar in people with T2D following a meal. This research will provide new knowledge about the regulation of blood sugar. This may also inform if ketone drinks could be used as a treatment for T2D.

Interventions

DIETARY_SUPPLEMENTKetone supplement

100 mL flavoured drink containing 0.3 g/kg ketone monoester ((R)-3-hydroxybutyl (R)-3-hydroxybutyrate; ΔG®, University of Oxford; https://www.deltagketones.com) consumed 30 min prior to a mixed meal tolerance test, on 2 occasions during test day

DIETARY_SUPPLEMENTPlacebo supplement

Placebo with stevia and bitter agent to flavour match, consumed 30 min prior to a mixed meal tolerance test, on 2 occasions during test day

Sponsors

University of British Columbia
CollaboratorOTHER
Medical Research Council
CollaboratorOTHER_GOV
University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Coded, known only to independent individual

Intervention model description

Randomised cross over trial counterbalanced for trial order

Eligibility

Sex/Gender
ALL
Age
41 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 41-70 years old 2. Body mass index 27-40 mg/m² 3. Type 2 diagnosis for more than 1 year 4. HbA1c \>6%

Exclusion criteria

1. Currently following ketogenic diet 2. Use of insulin 3. HbA1c \>10% 4. Recent weight loss (\>5kg in 6 months) 5. Recent eGFR \<30mL/min 6. Heart failure 7. Substance abuse 8. Cancer 9. Myocardial infarction within 6 months 10. Pregnancy or consideration of 11. Use of antipsychotic drugs

Design outcomes

Primary

MeasureTime frameDescription
Rate of endogenous glucose production4 hoursRate of endogenous glucose production over 4 hours in response to a meal measured by blood sample

Secondary

MeasureTime frameDescription
Exogenous glucose rate of appearance4 and 8 hoursExogenous rate of glucose appearance measured using the change in glucose enrichment/concentration over 4 and 8 hours following a meal
Total rate of glucose disappearance4 and 8 hoursTotal rate of glucose disappearance measured using the change in glucose enrichment/concentration over 4 and 8 hours following a meal
Rate of gluconeogenesis4 and 8 hoursRate of gluconeogenesis measured using the change in glucose enrichment/concentration over 4 and 8 hours following a meal
Rate of glycogenolysis4 and 8 hoursRate of glycogenolysis measured using the change in glucose enrichment/concentration over 4 and 8 hours following a meal
Beta-cell function4 and 8 hoursBeta-cell function using dynamic modelling of insulin/c-peptide secretion over 4 and 8 hours following a meal
Insulin concentration4 and 8 hoursInsulin concentration using ELISA assay over 4 and 8 hours following a meal
Total rate of glucose appearance4 and 8 hoursTotal rate of glucose appearance measured using the change in glucose enrichment/concentration over 4 and 8 hours following a meal
GLP-1 concentration4 and 8 hoursGLP-1 using ELISA assay over 4 and 8 hours following a meal
GIP concentration4 and 8 hoursGIP concentration using ELISA assay over 4 and 8 hours following a meal
Glycerol concentration4 and 8 hoursGlycerol concentration using colorimetric assay over 4 and 8 hours following a meal
Free fatty acid concentration4 and 8 hoursFree fatty acids using colorimetric assay over 4 and 8 hours following a meal
Ketone concentration4 and 8 hoursKetone concentration using colorimetric assay over 4 and 8 hours following a meal
Energy expenditure4 and 8 hoursEnergy expenditure using indirect calorimetry over 4 and 8 hours following a meal
Glucagon concentration4 and 8 hoursGlucagon concentration using ELISA assay over 4 and 8 hours following a meal

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026